Evidence map›Paper›PMID 34056481›Full record

ArticleACS omega2021

Novel Descriptors Derived from the Aggregation Propensity of Di- and Tripeptides Can Predict the Critical Aggregation Concentration of Longer Peptides.

Saeed Zanganeh, Loghman Firoozpour, Soroush Sardari, Ali Afgar, Reza Ahangari Cohan, Nasir Mohajel

Abstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Saeed ZanganehDepartment of Nanobiotechnology, New Technologies Research Group, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Loghman FiroozpourDepartment of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran 1416753955, Iran.
Soroush SardariDrug Design and Bioinformatics Unit, Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Ali AfgarResearch Center for Hydatid Disease in Iran, School of Medicine, Kerman University of Medical Sciences, Kerman 7616914115, Iran.
Reza Ahangari CohanDepartment of Nanobiotechnology, New Technologies Research Group, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Nasir MohajelDepartment of Molecular Virology, Pasteur Institute of Iran, Tehran 1316943551, Iran.ORCID 0000-0001-8883-4429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Self-assembling amphiphilic peptides have recently received special attention in medicine. Nonetheless, testing the myriad of combinations generated from at least 20 coded and several hundreds of noncoded amino acids to obtain candidate sequences for each application, if possible, is time-consuming and expensive. Therefore, rapid and accurate approaches are needed to select candidates from countless combinations. In the current study, we examined three conventional descriptor sets along with a novel descriptor set derived from the simulated aggregation propensity of di- and tripeptides to model the critical aggregation concentration (CAC) of amphiphilic peptides. In contrast to the conventional descriptors, the radial kernel model derived from the novel descriptor set accurately predicted the critical aggregation concentration of the test set with a residual standard error of 0.10. The importance of aromatic side chains, as well as neighboring amino acids in the self-assembly, was emphasized by analysis of the influential descriptors. The addition of very long peptides (70-100 residues) to the data set decreased the model accuracy and changed the influential descriptors. The developed model can be used to predict the CAC of self-assembling amphiphilic peptides and also to derive rules to apply in designing novel amphiphilic peptides with desired properties.

Identifiers

PMID34056481
PMCPMC8158804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.